MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of CAD 46.49 million. The enterprise value is 176.80 million.

Market Cap	46.49M
Enterprise Value	176.80M

Important Dates

The last earnings date was Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	389.17M
Shares Outstanding	n/a
Shares Change (YoY)	+2.55%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	349.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.20
PB Ratio	0.44
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	6.64
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.27, with an EV/FCF ratio of -30.83.

EV / Earnings	-7.54
EV / Sales	0.80
EV / EBITDA	10.27
EV / EBIT	124.17
EV / FCF	-30.83

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.18.

Current Ratio	1.05
Quick Ratio	0.30
Debt / Equity	1.18
Debt / EBITDA	6.08
Debt / FCF	-21.93
Interest Coverage	0.14

Financial Efficiency

Return on equity (ROE) is -20.10% and return on invested capital (ROIC) is 0.38%.

Return on Equity (ROE)	-20.10%
Return on Assets (ROA)	0.31%
Return on Invested Capital (ROIC)	0.38%
Return on Capital Employed (ROCE)	0.67%
Revenue Per Employee	293,387
Profits Per Employee	-30,303
Employee Count	832
Asset Turnover	0.77
Inventory Turnover	2.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.66% in the last 52 weeks. The beta is 3.15, so MariMed's price volatility has been higher than the market average.

Beta (5Y)	3.15
52-Week Price Change	-60.66%
50-Day Moving Average	0.14
200-Day Moving Average	0.19
Relative Strength Index (RSI)	39.60
Average Volume (20 Days)	28,763

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.12

Income Statement

In the last 12 months, MariMed had revenue of CAD 227.08 million and -23.45 million in losses. Loss per share was -0.06.

Revenue	227.08M
Gross Profit	88.45M
Operating Income	1.46M
Pretax Income	-10.00M
Net Income	-23.45M
EBITDA	17.71M
EBIT	1.46M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 10.35 million in cash and 125.79 million in debt, giving a net cash position of -115.44 million.

Cash & Cash Equivalents	10.35M
Total Debt	125.79M
Net Cash	-115.44M
Net Cash Per Share	n/a
Equity (Book Value)	106.27M
Book Value Per Share	0.23
Working Capital	3.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.00 million and capital expenditures -12.73 million, giving a free cash flow of -5.74 million.

Operating Cash Flow	7.00M
Capital Expenditures	-12.73M
Free Cash Flow	-5.74M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 38.95%, with operating and profit margins of 0.64% and -10.33%.

Gross Margin	38.95%
Operating Margin	0.64%
Pretax Margin	-4.40%
Profit Margin	-10.33%
EBITDA Margin	7.80%
EBIT Margin	0.64%
FCF Margin	n/a

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.55%
Shareholder Yield	-2.55%
Earnings Yield	-50.45%
FCF Yield	-12.34%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MariMed has an Altman Z-Score of 0.29. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.29
Piotroski F-Score	n/a